Join Deerland Probiotics & Enzymes at booth 3683 at Natural Products Expo West in Anaheim!
Deerland Probiotics & Enzymes Achieves Certification from Australia’s Therapeutic Goods Administration (TGA)
Globally Recognized Quality Certification Puts Deerland in Elite Class of Manufacturers
Deerland Probiotics & Enzymes, supplier of science-backed solutions for microbiome health, is pleased to announce that it is expanding its list of Good Manufacturing Practice (GMP) certifications with the addition of Australia’s Therapeutic Goods Administration (TGA) Certification at its Kennesaw, Georgia facilities. TGA certification represents that Deerland has demonstrated GMP management practices and systems in compliance with the manufacturing standards established by the Australian Government Department of Health and Ageing. With this most recent certification in Kennesaw and the existing certification renewal at the company’s Forsyth, MO facility, all of Deerland’s facilities have earned the elite status. In addition, the Denmark-based facility of Bifodan A/S, recently acquired by Deerland, has a mutual recognition agreement with Australia enabling it to produce TGA-certified products as well.
Acquisition Gives Deerland a Larger Global Footprint
Deerland Probiotics & Enzymes, a US-based supplier of science-backed solutions for microbiome health, announced today its acquisition of Bifodan A/S. Bifodan, based in Hundested, Denmark, is a life science company specialized in developing, manufacturing and distributing unique probiotic product solutions as private label dietary supplements, medical devices and OTC drugs.
Deerland is pleased to announce that it has earned Non-GMO Project verification for Solarplast®, the company’s branded enzyme-powered antioxidant ingredient for healthy aging and beauty from within.
Deerland is proud to announce that the FDA has issued a GRAS (Generally Recognized As Safe) No Objection Letter for its branded probiotic strain, Bacillus subtilis DE111®. A “Letter of No Objection” refers to the letter sent by the FDA confirming that they do not question the basis for the GRAS self-affirmation notification established and submitted by Deerland.
Deerland has announced the publication of a clinical study demonstrating efficacy of the bacteriophage (phage) cocktail PreforPro® in favorably supporting the gut microbiota and systemic markers. PreforPro is patented for use as a prebiotic.
SupplySide West is coming to the Mandalay Bay Las Vegas November 6-10, 2018, and Deerland Probiotics & Enzymes is excited to be participating. Deerland will have two booths at the Expo Hall— Booth # 4937 as well as the former National Enzyme Company location (Booth # 5543). In addition, Deerland will offer a special presentation by John Deaton, Ph.D., vice president of science and technology, on the topic of the Role of Probiotics in Sports Nutrition.
KENNESAW, GA (September 27, 2018) – Deerland Enzymes, Inc. (Deerland), a global leader in probiotics and enzymes, announced today it will now operate as Deerland Probiotics & Enzymes. The name change was made to reflect the company’s broader probiotic and enzyme expertise and commitment to innovation.
“In light of our rapid growth in the probiotic space and the recent acquisition of National Enzyme Company, we feel that now is the time to freshen up our logo and make our company name more direct, concise and reflective of our commitment to both probiotic and enzyme-based formulations & science,” said Scott Ravech, CEO.
The US Food and Drug Administration has issued a draft guidance on labeling of live microbial ingredients (probiotics) as colony forming units (CFUs) in addition to weight, as is currently specified in the regulations.
Read more at nutraingredients-usa.com
A study demonstrating a new way to test for the presence of gluten in enzyme supplements has been published in the Journal of Nutrition & Food Sciences. The study was motivated by the growing demand for gluten free products and the need for accurate testing methodologies for products claiming to meet the “gluten free” standard of less than 20 ppm, according to co-author Dr. John Deaton, vice president of science and technology for Deerland Probiotics & Enzymes.